Peapod Bio, Inc. launches with innovative assays and drug discovery services

Peapod Bio, Inc., a new contract research organization (CRO), launches to offer small molecule assay development and high-throughput screening (HTS) services using label-free and optical technologies. Our innovative mass spectrometry platform, powered by polymeric enrichment arrays (PEAs) and state-of-the-art MALDI instrumentation, accelerates the characterization of biochemical activities and binding interactions for virtually any target.

With a world-class team and breakthrough technologies, Peapod Bio is pushing the boundaries of innovation to advance the discovery of new therapeutic leads. Our team of assay experts collaborates with clients to engineer novel assays and deliver decision-making data faster than any other CRO.

Read more about it in the press release.